Amanta Healthcare Q2 FY27 Financial Performance

Revenue from operations reached Rs 83.13 crore for Q2 FY2027, with a net profit of Rs 4.86 crore for the same period.

Reader Takeaway: Revenue growth signals operational health, while the April 2027 debt call option creates immediate liquidity pressure for management.

What just happened

Amanta Healthcare released its financial results for the quarter ending September 30, 2026. The company reported a significant jump in quarterly revenue to Rs 83.13 crore from Rs 70.89 crore in the same period last year. Net profit for the half-year stood at Rs 8.17 crore, up from Rs 4.71 crore in the corresponding period of the previous year.

Why this matters

While topline growth is positive, the balance sheet contains a critical development. Term loans totaling Rs 91.92 crore have been reclassified as current liabilities. This shift occurred because lenders hold call options on these loans effective April 15, 2027, preventing the company from deferring the payment beyond the twelve-month reporting window.

Cash and IPO utilization

The company’s cash and cash equivalents fell sharply to Rs 1.67 crore as of September 30, 2026, down from Rs 81.01 crore at the start of the half-year. Meanwhile, the company has utilized Rs 100.83 crore of its total Rs 126.00 crore IPO proceeds, primarily for capital expenditure on machinery and civil construction.

Risks to watch

The primary risk is the liquidity challenge posed by the Rs 91.92 crore debt maturity in April 2027. Investors should watch for management's strategy regarding refinancing or repayment to avoid potential strain on the company's working capital.

What to track next

Shareholders should monitor upcoming disclosures regarding debt management and cash flow stabilization in the subsequent two quarters.